Senior Engineer, Primary Container, Biologics

Johnson & Johnson Johnson & Johnson · Pharma · Malvern, PA +1

Senior Engineer, Primary Container, Biologics at Johnson & Johnson will lead the development, selection, qualification, and lifecycle management of vial systems, pre-filled syringes, cartridges, cell therapy bags and emerging container technologies for new biologic drug products. The role ensures all primary containers comply with global regulatory, technical, and quality standards while driving innovation and operational excellence.

What you'd actually do

  1. Execute the global strategy for primary containers supporting biologics across the JJIM portfolio.
  2. Oversee development, qualification, and lifecycle management of vial systems, pre-filled syringes, cartridges, and new container technologies.
  3. Ensure compliance with global regulatory requirements and internal quality standards.
  4. Partner with cross-functional teams (R&D, Quality, Regulatory, Supply Chain) to align container solutions with product needs.
  5. Lead risk assessments and mitigation strategies for container systems.

Skills

Required

  • Bachelor's Degree in Packaging Engineering, Material Science, Biomedical Engineering, Chemical Engineering, or a related field
  • Advanced degree
  • Minimum of 5 years of experience in biologics drug product development, packaging science, or container–closure engineering
  • Proven leadership experience in pharmaceutical or biotech environments
  • Demonstrated experience with commercial biologics and regulatory submissions
  • Expertise in CCI testing, extractables/leachables, materials compatibility, and aseptic processing
  • Strong understanding of combination product regulations and CMC expectations
  • Strong leadership, team-building, and cross-functional collaboration skills
  • Excellent communication and strategic problem‑solving abilities
  • Ability to manage complex portfolios with multiple competing priorities

Nice to have

  • Specific expertise in pre-filled syringe systems

What the JD emphasized

  • Advanced therapy packaging
  • container–closure integrity (CCI)
  • extractables and leachables (E&L)
  • combination product regulations
  • commercial biologics
  • regulatory submissions